First Time Loading...

Precision BioSciences Inc
NASDAQ:DTIL

Watchlist Manager
Precision BioSciences Inc Logo
Precision BioSciences Inc
NASDAQ:DTIL
Watchlist
Price: 10.57 USD -0.84%
Updated: May 8, 2024

Intrinsic Value

DTIL's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. [ Read More ]

The intrinsic value of one DTIL stock under the Base Case scenario is 9.92 USD. Compared to the current market price of 10.57 USD, Precision BioSciences Inc is Overvalued by 6%.

Key Points:
DTIL Intrinsic Value
Base Case
9.92 USD
Overvaluation 6%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Precision BioSciences Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling DTIL stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Precision BioSciences Inc

Provide an overview of the primary business activities
of Precision BioSciences Inc.

What unique competitive advantages
does Precision BioSciences Inc hold over its rivals?

What risks and challenges
does Precision BioSciences Inc face in the near future?

Has there been any significant insider trading activity
in Precision BioSciences Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Precision BioSciences Inc.

Provide P/S
for Precision BioSciences Inc.

Provide P/E
for Precision BioSciences Inc.

Provide P/OCF
for Precision BioSciences Inc.

Provide P/FCFE
for Precision BioSciences Inc.

Provide P/B
for Precision BioSciences Inc.

Provide EV/S
for Precision BioSciences Inc.

Provide EV/GP
for Precision BioSciences Inc.

Provide EV/EBITDA
for Precision BioSciences Inc.

Provide EV/EBIT
for Precision BioSciences Inc.

Provide EV/OCF
for Precision BioSciences Inc.

Provide EV/FCFF
for Precision BioSciences Inc.

Provide EV/IC
for Precision BioSciences Inc.

Show me price targets
for Precision BioSciences Inc made by professional analysts.

What are the Revenue projections
for Precision BioSciences Inc?

How accurate were the past Revenue estimates
for Precision BioSciences Inc?

What are the Net Income projections
for Precision BioSciences Inc?

How accurate were the past Net Income estimates
for Precision BioSciences Inc?

What are the EPS projections
for Precision BioSciences Inc?

How accurate were the past EPS estimates
for Precision BioSciences Inc?

What are the EBIT projections
for Precision BioSciences Inc?

How accurate were the past EBIT estimates
for Precision BioSciences Inc?

Compare the revenue forecasts
for Precision BioSciences Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Precision BioSciences Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Precision BioSciences Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Precision BioSciences Inc compared to its peers.

Compare the P/E ratios
of Precision BioSciences Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Precision BioSciences Inc with its peers.

Analyze the financial leverage
of Precision BioSciences Inc compared to its main competitors.

Show all profitability ratios
for Precision BioSciences Inc.

Provide ROE
for Precision BioSciences Inc.

Provide ROA
for Precision BioSciences Inc.

Provide ROIC
for Precision BioSciences Inc.

Provide ROCE
for Precision BioSciences Inc.

Provide Gross Margin
for Precision BioSciences Inc.

Provide Operating Margin
for Precision BioSciences Inc.

Provide Net Margin
for Precision BioSciences Inc.

Provide FCF Margin
for Precision BioSciences Inc.

Show all solvency ratios
for Precision BioSciences Inc.

Provide D/E Ratio
for Precision BioSciences Inc.

Provide D/A Ratio
for Precision BioSciences Inc.

Provide Interest Coverage Ratio
for Precision BioSciences Inc.

Provide Altman Z-Score Ratio
for Precision BioSciences Inc.

Provide Quick Ratio
for Precision BioSciences Inc.

Provide Current Ratio
for Precision BioSciences Inc.

Provide Cash Ratio
for Precision BioSciences Inc.

What is the historical Revenue growth
over the last 5 years for Precision BioSciences Inc?

What is the historical Net Income growth
over the last 5 years for Precision BioSciences Inc?

What is the current Free Cash Flow
of Precision BioSciences Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Precision BioSciences Inc.

Financials

Balance Sheet Decomposition
Precision BioSciences Inc

Current Assets 136.4m
Cash & Short-Term Investments 116.7m
Receivables 12.8m
Other Current Assets 6.9m
Non-Current Assets 23.4m
Long-Term Investments 3.2m
PP&E 14.6m
Intangibles 400k
Other Non-Current Assets 5.2m
Current Liabilities 50m
Accounts Payable 3m
Accrued Liabilities 7.7m
Short-Term Debt 22.4m
Other Current Liabilities 16.9m
Non-Current Liabilities 90.9m
Other Non-Current Liabilities 90.9m
Efficiency

Earnings Waterfall
Precision BioSciences Inc

Revenue
48.7m USD
Operating Expenses
-92.5m USD
Operating Income
-43.7m USD
Other Expenses
-17.6m USD
Net Income
-61.3m USD

Free Cash Flow Analysis
Precision BioSciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

DTIL Profitability Score
Profitability Due Diligence

Precision BioSciences Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
ROIC is Increasing
Declining ROE
21/100
Profitability
Score

Precision BioSciences Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

DTIL Solvency Score
Solvency Due Diligence

Precision BioSciences Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Long-Term Solvency
Average D/E
39/100
Solvency
Score

Precision BioSciences Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DTIL Price Targets Summary
Precision BioSciences Inc

Wall Street analysts forecast DTIL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DTIL is 33.66 USD with a low forecast of 19.19 USD and a high forecast of 63 USD.

Lowest
Price Target
19.19 USD
82% Upside
Average
Price Target
33.66 USD
218% Upside
Highest
Price Target
63 USD
496% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

DTIL Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

DTIL Price
Precision BioSciences Inc

1M 1M
-22%
6M 6M
+2 590%
1Y 1Y
+1 144%
3Y 3Y
+31%
5Y 5Y
-17%
10Y 10Y
-39%
Annual Price Range
10.57
52w Low
0.286
52w High
18.56
Price Metrics
Average Annual Return -31.64%
Standard Deviation of Annual Returns 38.54%
Max Drawdown -99%
Shares Statistics
Market Capitalization 73.1m USD
Shares Outstanding 6 916 240
Percentage of Shares Shorted 5.14%

DTIL Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Precision BioSciences Inc Logo
Precision BioSciences Inc

Country

United States of America

Industry

Biotechnology

Market Cap

73.1m USD

Dividend Yield

0%

Description

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. The company is headquartered in Durham, North Carolina and currently employs 198 full-time employees. The company went IPO on 2019-03-28. The company is developing ex vivo allogeneic CAR T immunotherapies and in vivo therapies for genetic and infectious diseases with the application of its owned ARCUS genome editing platform. The firm's ARCUS platform is designed to deliver therapeutic-grade genome editing. Its ARCUS genome editing technology is for deoxyribonucleic acid (DNA) genome insertion, deletion and repair. Its ARCUS is based on a naturally occurring genome editing enzyme, I-CreI, that evolved in the algae Chlamydomonas reinhardtii to make specific cuts and DNA insertions in cellular DNA. Its Ex vivo Allogeneic CAR T Immunotherapy pipeline offers programs, including PBCAR0191, PBCAR19B, PBCAR269A and CD19 Combination with Foralumab. Its in-vivo Gene Correction pipeline offers three preclinical programs, including PBGENE-PCSK9, PBGENE-PH1 and PBGENE-HBV. Its subsidiaries include Precision PlantSciences, Inc. and Precision BioSciences UK Limited.

Contact

NORTH CAROLINA
Durham
302 E Pettigrew St Ste A100
+19193145512.0
http://precisionbiosciences.com/

IPO

2019-03-28

Employees

198

Officers

President, CEO & Director
Mr. Michael Amoroso
CFO & Principal Accounting Officer
Mr. John Alexander Kelly R.Ph.
General Counsel & Secretary
Mr. Dario Scimeca
Co-Founder & Chief Research Officer
Dr. Jefferson J. Smith Ph.D.
Director of Investor Relations & Finance
Mei Burris
Vice President of Quality & Compliance
Mr. Bruce Stevens
Show More
Senior Director of Corporate Communications
Maurissa Messier
Chief People Officer
Ms. Juli Blanche
Head of Manufacturing
Mr. Garrett Gincley
Chief Medical Officer
Dr. Alan F. List M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one DTIL stock?

The intrinsic value of one DTIL stock under the Base Case scenario is 9.92 USD.

Is DTIL stock undervalued or overvalued?

Compared to the current market price of 10.57 USD, Precision BioSciences Inc is Overvalued by 6%.